MENU
CNSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CNS Pharmaceuticals (CNSP) Earnings Date & Reports
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology... Show more
A.I. Advisor
published Earnings
CNSP is expected to report earnings to fall 90.55% to -68 cents per share on August 17
Q2'26
Est.
$-0.69
Q1'26
Beat
by $0.31
Q4'25
Missed
by $9.17
Q3'25
Missed
by $5.13
Q2'25
Missed
by $5.62
The last earnings report on May 14 showed earnings per share of -730 cents, beating the estimate of -761 cents. With 1.45K shares outstanding, the current market capitalization sits at 6.50M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
Industry Biotechnology
Profile
Details
Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
8
Web
https://www.cnspharma.com